Serum Metabolites and Cardiac Death in Patients on Hemodialysis.
作者信息
Hu Jiun-Ruey, Grams Morgan E, Coresh Josef, Hwang Seungyoung, Kovesdy Csaba P, Guallar Eliseo, Rhee Eugene P, Shafi Tariq
机构信息
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
Clin J Am Soc Nephrol. 2019 May 7;14(5):747-749. doi: 10.2215/CJN.12691018. Epub 2019 Apr 8.
Abstract
摘要
相似文献
1
Serum Metabolites and Cardiac Death in Patients on Hemodialysis.血液透析患者的血清代谢物与心源性死亡
Clin J Am Soc Nephrol. 2019 May 7;14(5):747-749. doi: 10.2215/CJN.12691018. Epub 2019 Apr 8.
2
Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.通过血液透析清除尿毒症潴留产物时，重要代谢产物也会被无差别地清除。
Clin Biochem. 2017 Dec;50(18):1078-1086. doi: 10.1016/j.clinbiochem.2017.09.012. Epub 2017 Sep 18.
3
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处：2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
4
A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.血浆长链酰基肉碱可预测新发生透析患者的心血管死亡率。
J Am Heart Assoc. 2013 Dec 5;2(6):e000542. doi: 10.1161/JAHA.113.000542.
5
High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.高草酸盐浓度与透析患者心源性猝死风险增加相关。
J Am Soc Nephrol. 2021 Sep;32(9):2375-2385. doi: 10.1681/ASN.2020121793. Epub 2021 Jul 19.
6
Blood metabolism study on protection of residual renal function of hemodialysis patients by traditional Chinese medicine Kidney Flaccidity Compound.中药肾萎方对血液透析患者残余肾功能保护作用的血液代谢研究
Cell Mol Biol (Noisy-le-grand). 2018 Apr 30;64(5):107-112.
7
Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study.血压与晚期慢性肾脏病和血液透析患者全因死亡率的关系：慢性肾功能不全队列研究。
Hypertension. 2015 Jan;65(1):93-100. doi: 10.1161/HYPERTENSIONAHA.114.04334. Epub 2014 Oct 6.
8
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function.非靶向代谢组学揭示 N,N,N-三甲基-L-丙氨酰-L-脯氨酸甜菜碱（TMAP）是肾功能的一种新型生物标志物。
Sci Rep. 2019 May 2;9(1):6831. doi: 10.1038/s41598-019-42992-3.
9
Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.血液透析患者血清不对称和对称二甲基精氨酸与发病率及死亡率
Am J Kidney Dis. 2017 Jul;70(1):48-58. doi: 10.1053/j.ajkd.2016.10.033. Epub 2017 Jan 12.
10
Sudden and cardiac death rates in hemodialysis patients.血液透析患者的猝死率和心源性死亡率。
Kidney Int. 1999 Apr;55(4):1553-9. doi: 10.1046/j.1523-1755.1999.00391.x.
引用本文的文献
1
Development of cardiovascular and all-cause mortality risk prediction models for maintenance hemodialysis patients based on metabolomics.基于代谢组学的维持性血液透析患者心血管疾病及全因死亡风险预测模型的开发
BMC Nephrol. 2025 Jul 10;26(1):372. doi: 10.1186/s12882-025-04291-0.
2
Temporal Changes in Blood Metabolome Among Patients on Hemodialysis.血液透析患者血液代谢组的时间变化
Kidney Int Rep. 2025 Apr 1;10(6):1761-1770. doi: 10.1016/j.ekir.2025.03.054. eCollection 2025 Jun.
3
A Metabolomics Approach to Identify Metabolites Associated With Mortality in Patients Receiving Maintenance Hemodialysis.一种代谢组学方法用于识别维持性血液透析患者中与死亡率相关的代谢物。
Kidney Int Rep. 2024 Jun 29;9(9):2718-2726. doi: 10.1016/j.ekir.2024.06.039. eCollection 2024 Sep.
4
Plasma metabolites and physical function in patients undergoing hemodialysis.血液透析患者的血浆代谢物与身体机能。
Sci Rep. 2024 Apr 10;14(1):8427. doi: 10.1038/s41598-024-58522-9.
5
Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience.糖尿病肾病中的精准医学：基于生活经历的叙述性综述
Can J Kidney Health Dis. 2023 Oct 30;10:20543581231209012. doi: 10.1177/20543581231209012. eCollection 2023.
6
Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease.利用多组学分析的全部潜力推动慢性肾脏病的研究与治疗
Front Nephrol. 2022 Jun 27;2:923068. doi: 10.3389/fneph.2022.923068. eCollection 2022.
7
The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits.透析液之间的代谢组学差异血浆图谱。旨在了解柠檬酸盐透析液临床益处的机制。
Front Physiol. 2022 Nov 16;13:1013335. doi: 10.3389/fphys.2022.1013335. eCollection 2022.
8
Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism-A Targeted Metabolomics Approach.乙酸盐与柠檬酸盐透析液对中间代谢物的影响：一种靶向代谢组学方法。
Int J Mol Sci. 2022 Oct 2;23(19):11693. doi: 10.3390/ijms231911693.
9
Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease.终末期肾病中高血压和心血管疾病的生理机制。
Curr Hypertens Rep. 2022 Oct;24(10):413-424. doi: 10.1007/s11906-022-01203-7. Epub 2022 Jun 16.
10
Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis.终末期肾病伴发抑郁患者的血清代谢组学研究：潜在的诊断生物标志物。
Ren Fail. 2021 Dec;43(1):1479-1491. doi: 10.1080/0886022X.2021.1994995.
Zotero 插件